Fatimah Al‐Ani

660 total citations
19 papers, 446 citations indexed

About

Fatimah Al‐Ani is a scholar working on Internal Medicine, Hematology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Fatimah Al‐Ani has authored 19 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Internal Medicine, 9 papers in Hematology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Fatimah Al‐Ani's work include Venous Thromboembolism Diagnosis and Management (11 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Fatimah Al‐Ani is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (11 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Fatimah Al‐Ani collaborates with scholars based in Canada, Spain and Iraq. Fatimah Al‐Ani's co-authors include Alejandro Lazo‐Langner, Martha Louzada, María‐Victoria Mateos, José María Bastida, Ian Chin‐Yee, Salimah Z. Shariff, Michael J. Kovacs, Renata R. Almeida, Anargyros Xenocostas and Janet Martin and has published in prestigious journals such as Blood, Thrombosis and Haemostasis and Thrombosis Research.

In The Last Decade

Fatimah Al‐Ani

17 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fatimah Al‐Ani Canada 8 183 148 134 97 88 19 446
Stephen MacDonald United Kingdom 12 151 0.8× 194 1.3× 76 0.6× 185 1.9× 58 0.7× 22 558
Louise Bowles United Kingdom 12 293 1.6× 123 0.8× 154 1.1× 343 3.5× 62 0.7× 18 804
Michael Newnham United Kingdom 9 142 0.8× 117 0.8× 70 0.5× 21 0.2× 42 0.5× 25 443
Maria Magnusson Sweden 11 122 0.7× 246 1.7× 128 1.0× 83 0.9× 36 0.4× 26 669
J D Nielsen Denmark 8 55 0.3× 133 0.9× 61 0.5× 114 1.2× 31 0.4× 9 427
Raphaël Le Mao France 12 210 1.1× 338 2.3× 109 0.8× 52 0.5× 105 1.2× 47 556
Akiva Diamond United States 4 294 1.6× 67 0.5× 190 1.4× 17 0.2× 108 1.2× 12 472
Nadin Elsayed United States 9 294 1.6× 133 0.9× 191 1.4× 28 0.3× 141 1.6× 42 652
Francesco Poletto Italy 6 483 2.6× 144 1.0× 245 1.8× 19 0.2× 146 1.7× 10 610
Shin Nunomiya Japan 12 41 0.2× 56 0.4× 34 0.3× 100 1.0× 48 0.5× 35 540

Countries citing papers authored by Fatimah Al‐Ani

Since Specialization
Citations

This map shows the geographic impact of Fatimah Al‐Ani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fatimah Al‐Ani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fatimah Al‐Ani more than expected).

Fields of papers citing papers by Fatimah Al‐Ani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fatimah Al‐Ani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fatimah Al‐Ani. The network helps show where Fatimah Al‐Ani may publish in the future.

Co-authorship network of co-authors of Fatimah Al‐Ani

This figure shows the co-authorship network connecting the top 25 collaborators of Fatimah Al‐Ani. A scholar is included among the top collaborators of Fatimah Al‐Ani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fatimah Al‐Ani. Fatimah Al‐Ani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Al‐Ani, Fatimah, et al.. (2022). Association of chronic diseases with mortality among hospitalized patients with COVID-19 treated with convalescent plasma: Evidence from a single center – Iraq. Journal of emergency medicine, trauma & acute care. 2022(2). 3 indexed citations
2.
Al‐Ani, Fatimah, et al.. (2020). Thrombosis risk associated with COVID-19 infection. A scoping review. Thrombosis Research. 192. 152–160. 254 indexed citations
3.
Al‐Ani, Fatimah, et al.. (2020). Development of a Clinical Prediction Rule for Venous Thromboembolism in Patients with Acute Leukemia. Thrombosis and Haemostasis. 120(2). 322–328. 23 indexed citations
4.
Tran, Christopher, et al.. (2020). Prevalence of Thrombophilia in Transient Ischemic Attack and Ischemic Stroke Patients. Blood. 136(Supplement 1). 3–3.
5.
Al‐Ani, Fatimah, et al.. (2019). Treatment of venous thromboembolism in acute leukemia: A systematic review. Thrombosis Research. 178. 1–6. 7 indexed citations
6.
Almeida, Renata R., Fatimah Al‐Ani, Alejandro Lazo‐Langner, & Martha Louzada. (2019). Efficacy and Safety of Direct Oral Anticoagulants in Obese Patients with Venous Thromboembolism. Blood. 134(Supplement_1). 3675–3675. 8 indexed citations
7.
Lazo‐Langner, Alejandro, et al.. (2018). Prevention of venous thromboembolism in pregnant patients with a history of venous thromboembolic disease: A retrospective cohort study. Thrombosis Research. 167. 20–25. 7 indexed citations
8.
Al‐Ani, Fatimah, et al.. (2018). Development of a Clinical Prediction Rule for the Risk of Venous Thromboembolism in Patients with Acute Leukemia. Blood. 132(Supplement 1). 2223–2223.
9.
Al‐Ani, Fatimah & Martha Louzada. (2017). Post‐transplant consolidation plus lenalidomide maintenance vs lenalidomide maintenance alone in multiple myeloma: A systematic review. European Journal Of Haematology. 99(6). 479–488. 5 indexed citations
10.
Al‐Ani, Fatimah, et al.. (2016). Retinal vein thrombosis: The Internist's role in the etiologic and therapeutic management. Thrombosis Research. 148. 118–124. 22 indexed citations
11.
Al‐Ani, Fatimah, José María Bastida, María‐Victoria Mateos, & Martha Louzada. (2016). Thromboprophylaxis in multiple myeloma patients treated with lenalidomide – A systematic review. Thrombosis Research. 141. 84–90. 33 indexed citations
12.
Lazo‐Langner, Alejandro, Ian Chin‐Yee, & Fatimah Al‐Ani. (2016). Eculizumab in the management of paroxysmal nocturnal hemoglobinuria: patient selection and special considerations. Therapeutics and Clinical Risk Management. Volume 12. 1161–1170. 26 indexed citations
13.
Louzada, Martha, Cyrus C. Hsia, Fatimah Al‐Ani, et al.. (2016). Randomized double-blind safety comparison of intravenous iron dextran versus iron sucrose in an adult non-hemodialysis outpatient population: A feasibility study. PubMed. 16(1). 7–7. 7 indexed citations
14.
Lazo‐Langner, Alejandro, Michael J. Kovacs, Fatimah Al‐Ani, et al.. (2015). Screening of Patients with Idiopathic Venous Thromboembolism for Paroxysmal Nocturnal Hemoglobinuria Clones. Thrombosis Research. 135(6). 1107–1109. 6 indexed citations
15.
Al‐Ani, Fatimah, et al.. (2015). Identifying venous thromboembolism and major bleeding in emergency room discharges using administrative data. Thrombosis Research. 136(6). 1195–1198. 32 indexed citations
16.
Al‐Ani, Fatimah, Martha Louzada, José María Bastida, & María‐Victoria Mateos. (2015). Thromboprophylaxis in Multiple Myeloma Patients Treated with Lenalidomide - a Systematic Review. Blood. 126(23). 2321–2321. 8 indexed citations
17.
Al‐Ani, Fatimah, et al.. (2015). Evaluating the Effect of Ethnicity on the Risk of Venous Thromboembolism (VTE): A Systematic Review. Blood. 126(23). 4714–4714. 2 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026